🥳 Techcrunch Announces JourneyOne's Initial Close
The first five people to share our announcement via LinkedIn or Twitter using the links below will get a special treat from our team!
📣 We have officially announced the initial close of our $10M debut 506c fund to invest in the venture-scale categories of the North American cannabis market! If you align with our thesis in cannabis, vision, mission, and values, we invite you to learn more and apply to become a member of the JourneyOne fam before our final close. LPs apply here.
Our Focus:
Stages: Pre-seed to Series A
Target portfolio size: 25-30
Check Size: $100K-$500K, $250K avg
Where we see the biggest winners: Tech, tech-enabled services, and companies with unique IP
Target Talent: Founders with robust networks that have executive-level management experience in cannabis or tangential industries
But wait… why are you raising a fund in a down market?! Because down markets = investor markets. We’ve seen 30-40% mark downs on valuations and we are positioned to take advantage of these opportunities. This is the time to invest!
Our Thesis
What makes cannabis a unique market for investment? Our industry can’t use…
Visa, Mastercard, Amex, Paypal, Stripe, etc Â
Fedex, USPS, and major couriers to transport product
Can’t advertise on traditional channels such as FB, Instagram, Google
No access to traditional federal banks
This industry is filled with vertical SaaS investment opps as we NEED customized software, platforms and infrastructure for this double digit billion dollar industry to operate.
What we love: companies that are solving critical industry problems with BIG TAMs that have the ability to service other highly regulated industries, not just cannabis.
Why Bet On the Cannabis Market
Who’s Betting On Us
Our LPs include a talented set of experts across the cannabis industry, traditional venture and business. They’re not just investors in our fund, they are strategic advisors with expertise in sectors that we invest in.
JourneyOne’s Flagship Portfolio
Nabis: The #1 tech-enabled distributor in California, serving 100% of retailers (900) in the state with a fast growing b2b wholesale marketplace
Komplyd: Regtech enterprise API platform that enables operators, technology platforms and financial service providers to operate in cannabis compliantly. Built by former Paypal employees
Cellibre: Biotech company that is the Beyond Meat of cannabis, creating lab developed cannabis compounds at scale
WUNDER: Effects based cannabis beverage brand that is disrupting the $250B alcohol industry. And, the fastest growing California beverage brand that has launched in 2020 or later according to Headset (61% monthly CAGR)
Plant People: Omni-channel B Corp doctor-formulated mushroom, hemp and plant supplements brand with over 2K points of distribution across the US
Meet Our Dream Team
Very few investors know how to navigate the cannabis industry's state by state market fragmentation and complex regulations. That’s why we curated a select group of industry pros that have built and acquired some of the leading companies in the market across tech, retail, brands, lab testing, and vertically integrated operators. The JourneyOne team has 45 years of combined cannabis expertise that is utilized to help founders and their teams accelerate into market leaders.
Also… have you ever seen a team like this on the capital side of cannabis?!
Infused In the Cannabis Community
We have put our hearts and souls into building a kickass community of truly talented entrepreneurs and investors in the industry.
Join Our Journey!
Our goal is to increase Limited Partner representation in our fund across different ethnic backgrounds, geographies, communities, and professions. We invite you to join our journey to make a positive impact across communities while investing in a market with unprecedented growth.
With gratitude,
Helene + JourneyOne
(PS: We are cannabis consumers!)
Disclaimer: JourneyOne Ventures is a 506c funds which allows them to publicly solicit their raise. All audiences are welcome to join however commitments into these funds must be by qualified accredited investors.